International Journal of Gynecologic Cancer: 21 (6)

Editorial

Editorial (1 August, 2011)
Uziel Beller

Letter to the Editor

Re: "Parametrial Involvement in FIGO Stage IB1 Cervical Carcinoma" (1 August, 2011)
Gillian M. Thomas

Review

Reasons for Diagnostic Delay in Gynecological Malignancies (1 August, 2011)
Mai Partridge Vandborg, René dePont Christensen, Jakob Kragstrup, Kasper Edwards, Peter Vedsted, Dorte Gilså Hansen, Ole Mogensen

Basic Science

Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer (1 August, 2011)
Seraina Schmid, Marcia Bieber, Fang Zhang, Mallory Zhang, Biao He, David Jablons, Nelson N.H. Teng
Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway (1 August, 2011)
Jia Wang, Jing Cai, Fang Han, Chun Yang, Qiaoling Tong, Ting Cao, Liying Wu, Zehua Wang
The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro (1 August, 2011)
Dongrui Deng, Shujie Liao, Xiangyang Bai, Wei Wang, Ni Sima, Qian Xu, Tao Zhu, Gang Xu, Jianfeng Zhou, Shixuan Wang, Li Meng, Ding Ma
CHFR Suppression by Hypermethylation Sensitizes Endometrial Cancer Cells to Paclitaxel (1 August, 2011)
Xiaoyun Wang, Yuebo Yang, Chengfang Xu, Lan Xiao, Huimin Shen, Xu Zhang, Tian Li, Xiaomao Li
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma (1 August, 2011)
Rong-jie Cheng, Wei-guo Deng, Chun-bo Niu, Yi-yang Li, Yan Fu

Ovarian Cancer

Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer: Brief Report (1 August, 2011)
Malgorzata E. Skaznik-Wikiel, Paniti Sukumvanich, Sushil Beriwal, Kristin K. Zorn, Joseph L. Kelley, Scott D. Richard, Thomas C. Krivak
Trends and Patterns of Ovarian Cancer Mortality in Belgrade, Serbia: A Joinpoint Regression Analysis (1 August, 2011)
Darija Kisic Tepavcevic, Bojana Matejic, Tatjana Gazibara, Tatjana Pekmezovic
Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer (1 August, 2011)
Ingirídur Skírnisdóttir, Tomas Seidal
Comparison of the Efficacy and Toxicity Between Radiotherapy and Chemotherapy in Nodal and Isolated Nonnodal Recurrence of Ovarian Cancer (1 August, 2011)
Maria Lee, Sang Wun Kim, San Hui Lee, Jiheum Paek, Ga Won Yim, Gwi Eon Kim, Sunghoon Kim, Jae Hoon Kim, Young Tae Kim, Eun Ji Nam
Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients (1 August, 2011)
Karina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, Anders Jakobsen
Feasibility of a Modified Outpatient Regimen of Intravenous/Intraperitoneal Chemotherapy in Optimally Debulked Stage III Ovarian Cancer Patients: A GEICO Study (1 August, 2011)
Ana Oaknin, Desamparado Roda, Antonio González-Martín, Luis Chiva, Jesús García-Donas, Ana de Juan, Andrés Redondo, Sergio Martínez, Yolanda García, Sílvia Catot, Jordi Ponce, J.M. del Campo, Andrés Cervantes, Andrés Poveda
Preoperative Multimodal Strategies for Risk Assessment of Adnexal Masses: Analysis of 1362 Cases in a Gynecologic Cancer Center (1 August, 2011)
Marc Philipp Radosa, Oumar Camara, Julia Vorwergk, Herbert Diebolder, Harald Winzer, Anke Mothes, Mieczyslaw Gajda, Ingo Bernard Runnebaum
Surgical and Medical Treatment of Clear Cell Ovarian Cancer: Results From the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 Retrospective Study (1 August, 2011)
Francescapaola Magazzino, Dionyssios Katsaros, Alessandro Ottaiano, Angiolo Gadducci, Carmela Pisano, Roberto Sorio, Emanuela Rabaiotti, Giovanni Scambia, Gennaro Cormio, Luca Scarampi, Stefano Greggi, Antonella Savarese, Marco Marinaccio, Paolo Scollo, Sandro Pignata

Uterine Cancer

Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study (1 August, 2011)
Ingrid Vandenput, An Capoen, Lieve Coenegrachts, Godelieve Verbist, Philippe Moerman, Ignace Vergote, Frédéric Amant
Defining Prognostic Variables in Recurrent Endometrioid Endometrial Cancer: A 15-Year Single-Institution Review (1 August, 2011)
Katharine M. Esselen, David M. Boruta, Marcela del Carmen, John O. Schorge, Annekathryn Goodman, Whitfield B. Growdon
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody (1 August, 2011)
Marta Bellone, Emiliano Cocco, Joyce Varughese, Stefania Bellone, Paola Todeschini, Karim El-Sahwi, Luisa Carrara, Federica Guzzo, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Deborah J. Marshall, Alessandro D. Santin

Cervical Cancer

Hydronephrosis as a Prognostic Indicator of Survival in Advanced Cervix Cancer (1 August, 2011)
Tana S. Pradhan, Haiou Duan, Evangelia Katsoulakis, Ghadir Salame, Yi-Chun Lee, Ovadia Abulafia
YY1 Is a Novel Potential Therapeutic Target for the Treatment of HPV Infection-Induced Cervical Cancer by Arsenic Trioxide (1 August, 2011)
Guifen He, Qian Wang, Yuqi Zhou, Xiaohua Wu, Lan Wang, Nadire Duru, Xiangtao Kong, Pingzhao Zhang, Bo Wan, Long Sui, Qisang Guo, Jian-Jian Li, Long Yu
Effects of Bufalin on the Proliferation of Human Choriocarcinoma Cells (1 August, 2011)
Noriyuki Takai, Tami Ueda, Terukazu Ishii, Naoko Kira, Masakazu Nishida, Yoshihiro Nishida, Kaei Nasu, Hisashi Narahara

Radiation Therapy

Reporting and Validation of Gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) Brachytherapy Recommendations for MR Image-Based Dose Volume Parameters and Clinical Outcome With High Dose-Rate Brachytherapy in Cervical Cancers: A Single-Institution Initial Experience (1 August, 2011)
Umesh Mahantshetty, Jamema Swamidas, Nehal Khanna, Reena Engineer, Nikhil H. Merchant, Deepak D. Deshpande, Shyamkishore Shrivastava
¹⁸F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Standard Uptake Value Ratio as an Indicator of Cervical Cancer Chemoradiation Therapeutic Response
(1 August, 2011)
Charles Kunos, Tomas Radivoyevitch, Fadi W. Abdul-Karim, Peter Faulhaber

Trophoblastic Disease

Analysis of Clinicopathologic Prognostic Factors in 9 Patients With Epithelioid Trophoblastic Tumor (1 August, 2011)
Xiaoyan Shen, Yang Xiang, Lina Guo, Tong Ren, Fengzhi Feng, Xirun Wan, Yu Xiao

Surgeons Corner

Double Prophylaxis for Deep Venous Thrombosis in Patients With Gynecologic Oncology Who Are Undergoing Laparotomy: Does Preoperative Anticoagulation Matter? (1 August, 2011)
Jenny M. Whitworth, Kellie E. Schneider, Peter J. Frederick, Michael A. Finan, Eddie Reed, Janelle M. Fauci, J. Michael Straughn, Rodney P. Rocconi
Preoperative Bowel Preparation in Gynecologic Oncology: A Review of Practice Patterns and an Impetus to Change (1 August, 2011)
Tiffany Wells, Marie Plante, Jessica N. McAlpine, the Communities of Practice Groups on behalf of the Society of Gynecologic Oncologists of Canada

Quality of Life

Clinical Study on the Efficacy of Fluvoxamine for Psychological Distress in Gynecologic Cancer Patients (1 August, 2011)
Nao Suzuki, Masato Ninomiya, Tomoko Maruta, Shinji Hosonuma, Norihito Yoshioka, Tatsuru Ohara, Yoshiko Nishigaya, Yoichi Kobayashi, Kazushige Kiguchi, Bunpei Ishizuka

Cooperative Groups

Prevalence of Human Papillomavirus Infection in Women in Portugal: The CLEOPATRE Portugal Study (1 August, 2011)
Angela Pista, Carlos Freire de Oliveira, Maria João Cunha, Maria Teresa Paixao, Odete Real, on behalf of the CLEOPATRE Portugal Study Group
Management of Cancer During Pregnancy: Obstetric and Neonatal Outcomes (1 August, 2011)
Isam M. Lataifeh, Mahmoud Al masri, Samer Barahmeh, Lian Otay, Nail Obeidat, Osama Badran, Ghaleb Darwazeh, Imad Jaradat
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer (1 August, 2011)
Andreas du Bois, Christian Marth, Jacobus Pfisterer, Philipp Harter, Felix Hilpert, Alain G. Zeimet, Jalid Sehouli

Main menu

Table of contents

August 2011 - Volume 21 - 6

Editorial

Letter to the Editor

Review

Basic Science

Ovarian Cancer

Uterine Cancer

Cervical Cancer

Radiation Therapy

Trophoblastic Disease

Surgeons Corner

Quality of Life

Cooperative Groups

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

August 2011 - Volume 21 - 6

Editorial

Letter to the Editor

Review

Basic Science

Ovarian Cancer

Uterine Cancer

Cervical Cancer

Radiation Therapy

Trophoblastic Disease

Surgeons Corner

Quality of Life

Cooperative Groups